Adult brain function and behavior are influenced by neuronal network formation during development. Consequently, disturbances of brain development may underlie the pathology of adult mental disorders, such as schizophrenia (SZ) and mood disorders. Consistent with this notion, genetic susceptibility factors for these disorders that have been recently indentified, including Disrupted-in-Schizophrenia-1 (DISC1) and PCM1, have roles during neurodevelopment and are likely to cooperate, forming molecular "pathways." Meanwhile, epidemiological studies have indicated that many environmental factors contribute to schizophrenia during neurodevelopment. P50 Schizophrenia Research Center at Johns Hopkins, therefore, is to address the key question of how defects of cortical development elicited by combinations of genetic and environmental risk factors lead to molecular, histological, and behavioral deficits associated with the frontal cortex in adulthood, which are relevant to SZ. Based on our preliminary studies, we hypothesize that DISC1 and its interactors are useful genetic probes for this study. Accordingly, the four major aims of this entire center are as follows: 1) to clarify the mechanisms whereby several different combinations of DISC1 and interactors (e.g., Karilin-7, PCM1, RPGRIP1L, CRMP2, nNOS, and NDEL1) mediate distinct processes during neurodevelopment, which in turn affect postnatal brain maturation and result in deficits of the frontal cortex and behavioral abnormalities relevant to SZ;2) to determine how environmental factors relevant to SZ (prenatal immune activation, postnatal activation of complement cascade, and postnatal infection of Toxoplasma Gondii) influence genetic vulnerability associated with DISCI, which eventually contribute to the deficits of the frontal cortex and behavioral abnormalities relevant to SZ;3) to identify molecular targets for possible biomarkers of SZ and SZ-associated endophenotypes by comparing altered expression profiles in preclinical models and human tissues;4) to identify rare genetic variants associated with SZ and/or some endophenotypes associated with SZ by pinpointing novel candidates for genetic sequencing from biological studies. In this center, 6 projects and 2 cores will collaborate to achieve these scientific goals.
This multifaceted proposal systematically arranged by experts of many different areas is expected to address neurodevelopmental cascades for schizophrenia elicited by genetic and environmental risk factors of the disorder. The findings are expected to be an important basis for early identification for patients, novel biomarkers, and novel therapeutic strategies for the disease (especially its early intervention).
|Shahani, N; Seshadri, S; Jaaro-Peled, H et al. (2015) DISC1 regulates trafficking and processing of APP and A? generation. Mol Psychiatry 20:874-9|
|Xiao, J; Li, Y; Prandovszky, E et al. (2014) MicroRNA-132 dysregulation in Toxoplasma gondii infection has implications for dopamine signaling pathway. Neuroscience 268:128-38|
|Dada, Tahani; Rosenzweig, Jason M; Al Shammary, Mofeedah et al. (2014) Mouse model of intrauterine inflammation: sex-specific differences in long-term neurologic and immune sequelae. Brain Behav Immun 38:142-50|
|Bernier, Raphael; Golzio, Christelle; Xiong, Bo et al. (2014) Disruptive CHD8 mutations define a subtype of autism early in development. Cell 158:263-76|
|Abazyan, Sofya; Yang, Eun Ju; Abazyan, Bagrat et al. (2014) Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism. J Neurosci Res 92:1659-68|
|Posporelis, Sotirios; Sawa, Akira; Smith, Gwenn S et al. (2014) Promoting careers in academic research to psychiatry residents. Acad Psychiatry 38:185-90|
|Xia, Meng; Abazyan, Sofya; Jouroukhin, Yan et al. (2014) Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia. Schizophr Res :|
|Severance, Emily G; Gressitt, Kristin L; Yang, Shuojia et al. (2014) Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder. Bipolar Disord 16:230-40|
|Severance, Emily G; Gressitt, Kristin L; Buka, Stephen L et al. (2014) Maternal complement C1q and increased odds for psychosis in adult offspring. Schizophr Res 159:14-9|
|Hayashi-Takagi, Akiko; Araki, Yoichi; Nakamura, Mayumi et al. (2014) PAKs inhibitors ameliorate schizophrenia-associated dendritic spine deterioration in vitro and in vivo during late adolescence. Proc Natl Acad Sci U S A 111:6461-6|
Showing the most recent 10 out of 43 publications